Arkolith/Insider Trading/IMPL/Form 4

Vivo Capital Surplus Fund VIII, L.P.

10% OwnerIMPEL PHARMACEUTICALS INC (IMPL) · full profile →Form 4 · filed Dec 19, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$74K
Net Open-Market Flow
-$74K
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 19, 2023Sell(S)29K$0.08$2K280K
Dec 19, 2023Sell(S)209K$0.08$17K2.0M
Dec 18, 2023Sell(S)209K$0.11$23K2.2M
Dec 18, 2023Sell(S)29K$0.11$3K309K
Dec 15, 2023Sell(S)12K$0.29$3K338K
Dec 15, 2023Sell(S)88K$0.29$26K2.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-23-097043) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML